This UCSF postdoctoral training program, entering its 24th year, develops substance use disorders (SUD) treatment and services researchers. The training focuses on four areas: a) clinical trials of behavioral, pharmacological and psychosocial interventions, in both practice-based and community settings; b) services research, including organizational change, in health care systems; c) psychosocial and biological factors that interact with treatments, including genetics and neuroimaging; and d) treatment and services research in complex, comorbid populations. Trainees are admitted for two years with possibility of a third year. The exceptional trainee may enter for a one-year training program. To date the program has successfully trained 60 doctoral level psychologists, physicians, public health, and policy professionals for academic and research careers. The program's graduates have embarked on fruitful careers to improve SUD treatment through scientific study. In the most recent funding cycle the program focused on linking with mental health disciplines, conducted rigorous program evaluation, extended its emphasis on technology, and enhanced its strength in HIV health care and prevention. During the next five years we focus on technology; evolving opportunities through health care reform; health care for underserved populations such as youth and sexual and racial/ethnic minorities; and SUD and HIV prevention and care. The program is based in an environment with outstanding and highly relevant resources, including linkages with diverse clinical sites and a variety of academic centers and activities that supplement the training experience. The program is led by the Director and 4 Site Directors, an Executive Committee of Investigators, and has guidance from a Scientific and Training Advisory Committee. Core faculty members have backgrounds including psychology, psychiatry, biostatistics, nursing, public health, and epidemiology. These faculty have strong histories of mentorship, extensive experience in obtaining extramural funding, and ongoing research productivity in SUD treatment and services research. New faculty members have joined the program, bringing important lines of inquiry, research settings, and methods. The result is a scientifically productive environment that allows trainees to draw on multiple perspectives in designing and completing treatment and services research. The expectation is that program graduates will conduct independent, methodologically rigorous and clinically relevant SUD treatment and services research, contributing to the knowledge base in the field.

Public Health Relevance

This training program at the University of California, San Francisco mentors the next generation of postdoctoral scientists in substance use disorder treatment and services research. As substance use disorders science develops, and more is learned about the behavioral, social, and genetic basis of this persistent disorder and the association with problems such as HIV and health disparities, investigators need postdoctoral training to master the skills and concepts essential to producing successful research. Consistent with our current training program we request support for 5 postdoctoral trainees at any given time, with the overarching goal of improving substance use disorders treatment by addressing the needs for both effective and efficient interventions for the many people affected by substance use disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
2T32DA007250-26
Application #
9490235
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Lao, Guifang
Project Start
1991-09-30
Project End
2024-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
26
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Psychiatry
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Pagano, Anna; Gubner, Noah R; Le, Thao et al. (2018) Differences in tobacco use prevalence, behaviors, and cessation services by race/ethnicity: A survey of persons in addiction treatment. J Subst Abuse Treat 94:9-17
Ramo, Danielle E; Bahorik, Amber L; Delucchi, Kevin L et al. (2018) Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status. J Psychoactive Drugs 50:43-53
Horyniak, Danielle; Strathdee, Steffanie A; West, Brooke S et al. (2018) Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico. Drug Alcohol Depend 185:298-304
Bahorik, Amber L; Sterling, Stacy A; Campbell, Cynthia I et al. (2018) Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J Affect Disord 241:8-14
Vogel, Erin A; Rubinstein, Mark L; Prochaska, Judith J et al. (2018) Associations between marijuana use and tobacco cessation outcomes in young adults. J Subst Abuse Treat 94:69-73
Cooke, Alexis C; Knight, Kelly R; Miaskowski, Christine (2018) Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care. Int J Drug Policy 63:23-28
Kim-Mozeleski, Jin E; Tsoh, Janice Y; Ramirez-Forcier, Joseph et al. (2018) Smoking Predicts Food Insecurity Severity among Persons Living with HIV. AIDS Behav 22:2861-2867
Meacham, Meredith C; Roesch, Scott C; Strathdee, Steffanie A et al. (2018) Perceived Treatment Need and Latent Transitions in Heroin and Methamphetamine Polydrug Use among People who Inject Drugs in Tijuana, Mexico. J Psychoactive Drugs 50:62-71
Bahorik, Amber L; Campbell, Cynthia I; Sterling, Stacy A et al. (2018) Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry Res 259:316-322
Gubner, Noah R; Williams, Denise D; Pagano, Anna et al. (2018) Menthol cigarette smoking among individuals in treatment for substance use disorders. Addict Behav 80:135-141

Showing the most recent 10 out of 165 publications